PTJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


PHYS THER
Vol. 85, No. 12, December 2005, pp. 1372-1388

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lovering, R. M
Right arrow Articles by Bloch, R. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lovering, R. M
Right arrow Articles by Bloch, R. J

Perspectives

The Muscular Dystrophies: From Genes to Therapies

Richard M Lovering, Neil C Porter and Robert J Bloch

RM Lovering, PT, PhD, is Research Associate, Department of Physiology, University of Maryland, School of Medicine, 685 W Baltimore St, Baltimore, MD 21201 (USA) (rlovering{at}som.umaryland.edu).
NC Porter, MD, is Assistant Professor, Department of Neurology, University of Maryland, School of Medicine
RJ Bloch, PhD, is Professor, Department of Physiology, University of Maryland, School of Medicine

Address all correspondence to Dr Lovering

The genetic basis of many muscular disorders, including many of the more common muscular dystrophies, is now known. Clinically, the recent genetic advances have improved diagnostic capabilities, but they have not yet provided clues about treatment or management. Thanks to better management strategies and therapeutic interventions, however, many patients with a muscular dystrophy are more active and are living longer. Physical therapists, therefore, are more likely to see a patient with a muscular dystrophy, so understanding these muscle disorders and their management is essential. Physical therapy offers the most promise in caring for the majority of patients with these conditions, because it is unlikely that advances in gene therapy will significantly alter their clinical treatment in the near future. This perspective covers some of the basic molecular biological advances together with the clinical manifestations of the muscular dystrophies and the latest approaches to their management.

Key Words: Muscular dystrophy • Skeletal muscle




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
P. S. Zammit
All muscle satellite cells are equal, but are some more equal than others?
J. Cell Sci., September 15, 2008; 121(18): 2975 - 2982.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Physical Therapy Association.